Published on Monday February 05, 2024

Smooth Drug Development January 2024 News Release

We are working on the following new projects:

  • We have successfully passed quality control of a global company and we are finalizing a contract for data management activities in observational programs.
  • A contract for a phase III study with Adalimumab was signed.
  • We are signing a contract for two articles based on trial results, performed by our company. One article will be published in an international magazine.
  • We were awarded with two BE projects with Duloxetine and Nimesulide by our long-term client.
  • Smooth signed a contract for regulatory services in an observational program in oncology.
  • A full services contract for a phase I trial with dornase alpha was signed. The trial will be conducted in Kazakhstan.

We are happy to reach the following milestones in our projects:

  • Clinical part was performed in a Liraglutide trial.
  • Three sites were opened in a Tegoprazan trial.
  • Monitoring visits were performed in Uzbekistan in the observational program of multivitamins in pregnant and childbearing women.
  • Start-up was performed in a Tadalafil trial.